Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by inthnoon Apr 08, 2023 11:55am
527 Views
Post# 35385268

The number of Board Members

The number of Board MembersI am hoping that this will help to clear up some confusion.
I emailed Jon last year when onc exceeded the number of directors (6 at the time) and added Rigby and asked how this was possible.
I was told that there was a provision in their bylaws, agenda or whatever you would like to call to allow for the additional board members with out the consultation of shareholders.
That is why it is fixed at 7 this year as that is the number of members that we have AT THIS MOMENT IN TIME as they at this time have no intention of adding more but if needed could add up to an additonal 4 board members.
I have seen this in the past with other companies where they have either a partnership or equity investment which allows a person from the other company to have a seat on the board to help with accountability and oversight.
It is obvious or hopefully so that the additon of Rigby was necessary in the operations of ONC as all on this board are in general agreement that he was added to facilitate either a partnership or BO of the company or so we are hoping.
<< Previous
Bullboard Posts
Next >>